-
Nvidia CEO Jensen Huang has now given a reassurance to people as the anxiety is growing among white-collar workers over potential AI-driven layoffs. Huang has said that the jobs are not defined by the tools used to perform them. According to a report by Fortune, speaking on the Lex Fridman Podcast, Huang acknowledged the widespread…
-
Over 2,000 doctors in eight states who have completed postgraduate studies have sought intervention from the country’s apex medical regulator, saying legal proceedings have stalled their final exams for over a year, casting uncertainty over their careers. A nationwide body of doctors representing postgraduate students of the College of Physicians and Surgeons (CPS) has asked…
-
A new Development Control Plan (DCP) for University Hospital Galway, as well as an associated Strategic Assessment Review (SAR) has been completed and is approved by the HSE Board, the latest meeting of the Regional Health Forum heard last week.
-
STAMFORD, CT, April 02, 2026 /24-7PressRelease/ — Stephen H. Liebowitz, DHA, MHA, has been included in Marquis Who’s Who. As in all Marquis Who’s Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account…
-
Russia has administered the first personalized vaccine to a clinical patient, a man with stage three skin cancer Read Full Article at RT.com
-
Nvidia CEO Jensen Huang’s advice to workers scared of AI: You’re confusing your job with the tools you use to do it
-
QUEENSBURY, N.Y. — Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, will attend the Society of Interventional Radiology (SIR) 2026 Annual Scientific Meeting, taking place April 11–15, 2026, in Toronto, Canada. At the event, Delcath’s Hepatic Delivery System for use in percutaneous…
-
TORONTO, April 01, 2026 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, is pleased to announce that the interventional MRI (“iMRI”) TULSA Procedure™ will be highlighted in several presentations at the 2026…
-
TORONTO, April 01, 2026 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, is pleased to announce that the interventional MRI (“iMRI”) TULSA Procedure™ will be highlighted in several presentations at the 2026…
-
John Lynch stood at a podium in Phoenix on Sunday and did something no NFL general manager has ever had to do: announce the results of a scientific investigation into whether his own facility was harming players.